Progenics Corporation is a biopharmaceutical company based in Columbus, Ohio, specializing in the development of innovative therapeutics for the treatment of cancer. The organization focuses on leveraging advanced technologies in molecular imaging and targeted therapies to enhance patient outcomes. Progenics is committed to addressing unmet medical needs through its research in oncology, aiming to improve the quality of life for patients facing challenging diagnoses.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#62 in Columbus, OH

#1,008 in Ohio

#23,838 in US

#45,039 in the World

Columbus, OH, United States of America

Progenics Corporation

Forward Citations = 271

10 inventors:

Dennis Joseph Denen (4 out of 45 patents)

Norman Applezweig (4 out of 5 patents)

John S Thomas (2 out of 10 patents)

4. George Krsek (2 out of 4 patents)

5. Robert C Betz (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Progenics Corporation. Retrieved from https://idiyas.com/company/progenics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]